Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YY001 in Adult Upper Limb Spasticity
NCT07478822Phase 3Recruiting
- Sponsor
- Claruvis Pharmaceutical
- Start
- Mar 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of YY001 in Upper limb spasticity, sponsored by Claruvis Pharmaceutical. Started Mar 2026; status: recruiting.
02
Drugs
YY001
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT07478822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07478822.